Keyword Index
Browse for an article via relevant keywords across our entire electronic archive
Search results for: M
Results 71 - 80 of 606 shown below
management LSIL
C Scheungraber, N Kleekamp and A Schneider
Management of low-grade squamous intraepithelial lesions of the uterine cervix
doi:10.1038/sj.bjc.6601415
Abstract | Full article | PDF
manganese
Y Takehara, H Sakahara, H Masunaga, S Isogai, N Kodaira, H Takeda, T Saga, S Nakajima and I Sakata
Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice
doi:10.1054/bjoc.2001.1802
manganese superoxide dismutase
K Kahlos, P Pääkkö, E Kurttila, Y Soini and V L Kinnula
Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma
doi:10.1054/bjoc.1999.1037
mannose 6-phosphate/insulin-like growth factor-2 receptor
N Sedlaczek, A Hasilik, P Neuhaus, D Schuppan and H Herbst
Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis
doi:10.1038/sj.bjc.6600777
Abstract | Full article | PDF
mantle cell lymphoma (MCL)
C Schrader, D Janssen, W Klapper, J-U Siebmann, P Meusers, G Brittinger, M Kneba, M Tiemann and R Parwaresch
Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma
advance online publication, 2005-09-27 00:00:00.000;
doi:10.1038/sj.bjc.6602795
Abstract | Full article | PDF
Mantova
V Ascoli, S Belli, M Benedetti, S Trinca, P Ricci and P Comba
High incidence of classic Kaposi's sarcoma in Mantua, Po Valley, Northern Italy (1989-1998)
doi:10.1054/bjoc.2001.1912
manumycin
A Di Paolo, R Danesi, D Nardini, G Bocci, F Innocenti, S Fogli, S Barachini, A Marchetti and G Bevilacqua
Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumourcells
doi:10.1054/bjoc.1999.1018
MAP kinase
X Gu, J Niu, D J Dorahy, R Scott and M V Agrez
Integrin
v
6-associated ERK2 mediates MMP-9 secretion in colon cancer cellsdoi:10.1038/sj.bjc.6600480
Abstract | Full article | PDF
-
L McMillan, S K Butcher, J Pongracz and J M Lord
Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases
doi:10.1038/sj.bjc.6600793
Abstract | Full article | PDF
-
K S M Smalley, R Contractor, N K Haass, J T Lee, K L Nathanson, C A Medina, K T Flaherty and M Herlyn
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels
advance online publication, 2007-01-23 00:00:00.000;
doi:10.1038/sj.bjc.6603596
Abstract | Full article | PDF
-
P A Havre, M Abe, Y Urasaki, K Ohnuma, C Morimoto and N H Dang
CD26 expression on T cell lines increases SDF-1-
-mediated invasionadvance online publication, 2009-08-04 00:00:00.000;
doi:10.1038/sj.bjc.6605236
Abstract | Full article | PDF
-
Y Ueoka, K Kato, Y Kuriaki, S Horiuchi, Y Terao, J Nishida, H Ueno and N Wake
Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway
doi:10.1054/bjoc.1999.1016
-
S Ding, M Chamberlain, A McLaren, L-b Goh, I Duncan and C R Wolf
Cross-talk between signalling pathways and the multidrug resistant protein MDR-1
doi:10.1054/bjoc.2001.2044
-
X M Liu, L G Wang, W Kreis, D R Budman and L M Adams
Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells
doi:10.1054/bjoc.2001.2107
MAPK
N Magné, J L Fischel, A Dubreuil, P Formento, M-F Poupon, P Laurent-Puig and G Milano
Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ('Iressa')
doi:10.1038/sj.bjc.6600299
Abstract | Full article | PDF
-
W Jin, L Wu, K Liang, B Liu, Y Lu and Z Fan
Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells
doi:10.1038/sj.bjc.6601048
Abstract | Full article | PDF
-
E O'Neill and W Kolch
Conferring specificity on the ubiquitous Raf/MEK signalling pathway
doi:10.1038/sj.bjc.6601488
Abstract | Full article | PDF
-
S Vicent, J M López-Picazo, G Toledo, M D Lozano, W Torre, C Garcia-Corchón, C Quero, J-C Soria, S Martín-Algarra, R G Manzano and L M Montuenga
ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours
doi:10.1038/sj.bjc.6601644
Abstract | Full article | PDF
-
M Aubele, A K Walch, N Ludyga, H Braselmann, M J Atkinson, B Luber, G Auer, S Tapio, T Cooke and J M S Bartlett
Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
advance online publication, 2008-09-09 00:00:00.000;
doi:10.1038/sj.bjc.6604660
Abstract | Full article | PDF
-
R K Singh, T S Lange, K K Kim, A P Singh, N Vorsa and L Brard
Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells
advance online publication, 2008-11-11 00:00:00.000;
doi:10.1038/sj.bjc.6604778
Abstract | Full article | PDF
-
C Simon, M J Hicks, A J Nemechek, R Mehta, B W O'Malley Jr, H Goepfert, C M Flaitz and D Boyd
PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma
doi:10.1038/sj.bjc.6690537
-
A Budillon, E Di Gennaro, M Caraglia, D Barbarulo, A Abbruzzese and P Tagliaferri
8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor
doi:10.1038/sj.bjc.6690820
-
J Ostrowski, M Woszczynski, P Kowalczyk, T Wocial, E Hennig, L Trzeciak, P Janik and K Bomsztyk
Increased activity of MAP, p70S6 and p90rs kinases is associated with AP-1 activation in spontaneous liver tumours, but not in adjacent tissue in mice
doi:10.1054/bjoc.1999.1040
-
B Liu, M Fang, Y Lu, Y Lu, G B Mills and Z Fan
Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells
doi:10.1054/bjoc.2001.1910
MAPK AP-1
L O Murphy, M W Cluck, S Lovas, F Ötvös, R F Murphy, A V Schally, J Permert, J Larsson, J A Knezetic and T E Adrian
Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions
doi:10.1054/bjoc.2001.1698
